Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-994X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression ; volume:11 ; number:1 ; day:23 ; month:12 ; year:2019 ; pages:1-18 ; date:12.2019
Genome medicine ; 11, Heft 1 (23.12.2019), 1-18, 12.2019
- Creator
-
Kazachenka, Anastasiya
Young, George R.
Attig, Jan
Kordella, Chrysoula
Lamprianidou, Eleftheria
Zoulia, Emmanuela
Vrachiolias, George
Papoutselis, Menelaos
Bernard, Elsa
Papaemmanuil, Elli
Kotsianidis, Ioannis
Kassiotis, George
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13073-019-0707-x
- URN
-
urn:nbn:de:101:1-2020032713364915572218
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kazachenka, Anastasiya
- Young, George R.
- Attig, Jan
- Kordella, Chrysoula
- Lamprianidou, Eleftheria
- Zoulia, Emmanuela
- Vrachiolias, George
- Papoutselis, Menelaos
- Bernard, Elsa
- Papaemmanuil, Elli
- Kotsianidis, Ioannis
- Kassiotis, George
- SpringerLink (Online service)
Other Objects (12)
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes
Drug development in higher-risk myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes
Drug development in higher-risk myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes